A Study to Explore the Role of Gut Flora in COVID-19 Infection

Purpose

This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.

Conditions

  • Gut Microbiome
  • Gastrointestinal Microbiome
  • COVID
  • COVID-19
  • Corona Virus Infection
  • Coronavirus
  • Coronaviridae Infections
  • Coronavirus 19
  • Coronavirus-19
  • COVID 19

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study 2. Male or female of 18 years of age or older 3. Diagnosis of COVID-19 infection by RT- PCR within 1 week of Screening

Exclusion Criteria

  1. Refusal to sign informed consent form 2. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy. 3. Postoperative stoma, ostomy, or ileoanal pouch 4. Treatment with total parenteral nutrition

Study Design

Phase
Study Type
Observational
Observational Model
Other
Time Perspective
Other

Arm Groups

ArmDescriptionAssigned Intervention
General Population The general population will have their microbiome sequenced from stool samples provided.
  • Other: There is no intervention in this study
    There is no intervention in this study

Recruiting Locations

ProgenaBiome
Ventura, California 93003
Contact:
Sabine Hazan, MD
805-339-0549
drsabinehazan@progenabiome.com

More Details

NCT ID
NCT04359836
Status
Recruiting
Sponsor
ProgenaBiome

Study Contact

Sabine Hazan, MD
805-339-0549
drsabinehazan@progenabiome.com

Detailed Description

In this study the stool of patients who are being treated for COVID-19 will be tested during treatment and then again following treatment to determine if the virus is shed in the stool during infection, afterwards, or both.